Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.
BACKGROUND
Through the development of gene diagnostic techniques, late-onset transthyretin Met30-associated familial amyloid polyneuropathy (FAP TTR Met30) has been shown to be more prevalent than is generally believed.


OBJECTIVE
To examine the electrophysiological features of late-onset FAP TTR Met30 unrelated to endemic foci.


METHODS
Nerve conduction findings in 44 cases with an onset of more than 50 years of age in a non-endemic area were assessed and compared with findings from 21 earlier-onset cases related to endemic foci.


RESULTS
The extent of the reduction of the compound muscle action potential and, especially, the sensory nerve action potential was more profound in the late-onset group even when the decline of these indices with aging in normal control subjects was taken into account. The feature of predominant lower-limb involvement seemed to be more conspicuous in the late-onset group. Electrophysiological indices tended to be aggravated as the duration of neuropathic symptoms increased in the early-onset group, while most of these indices in the lateonset group did not show this correlation. A slowing of conduction velocity and a prolongation of distal latency, which suggests demyelination, were conspicuous in some patients. Pathologically, a predominant loss of small-fibers was not conspicuous in sural nerve biopsy specimens from late-onset patients. Large myelinated fiber density showed a negative correlation with the disease duration in early-onset cases, but not in late-onset cases.


CONCLUSIONS
Electrophysiological differences between late- and early-onset cases were present, probably reflecting the different underlying pathogenic mechanisms of neuropathy. The demyelinating feature does not exclude the possibility of this disease.
Koike
Haruki
H
Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Kawagashira
Yuichi
Y
Iijima
Masahiro
M
Yamamoto
Masahiko
M
Hattori
Naoki
N
Tanaka
Fumiaki
F
Hirayama
Masaaki
M
Ando
Yukio
Y
Ikeda
Shu-ichi
S
Sobue
Gen
G
D000200:Action Potentials; D000328:Adult; D000367:Age Factors; D017668:Age of Onset; D000368:Aged; D000682:Amyloid / Q000235:genetics*; D028227:Amyloid Neuropathies, Familial / Q000453:epidemiology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007866:Leg / Q000294:innervation / Q000503:physiopathology; D008297:Male; D008475:Median Nerve / Q000503:physiopathology; D008875:Middle Aged; D009413:Nerve Fibers, Myelinated / Q000473:pathology; D009431:Neural Conduction; D011228:Prealbumin / Q000235:genetics*; D011984:Sensory Receptor Cells / Q000473:pathology / Q000502:physiology; D013497:Sural Nerve / Q000473:pathology; D013979:Tibial Nerve / Q000503:physiopathology
D000682:Amyloid; D011228:Prealbumin; C041120:amyloid prealbumin